A Relative Bioavailability Study of Sertraline HCl 100 mg Tablets Under Non-fasting Conditions
Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
To compare the rate of absorption and oral bioavailability of a test formulation of
Sertraline 100 mg tablets manufactured by Purepac Pharmaceutical Company to an equivalent
oral dose of the commercially available reference product, Zoloft® manufactured by Pfizer
Inc. Following an overnight fast of at least 10 hours, subjects will consume a standard
high-calorie, high-fat breakfast meal. This standard breakfast will begin 30 minutes prior to
each dose.